The Healing Properties Of CBD

The relationship in between infection and traditional antibiotics

Could CBD be useful in the battle against resistant bacterial pressures? The arise from the University of Queensland in Australia suggest that it is possible. However before taking a look at the research study in depth, it is useful to comprehend the advancement of the relationship in between germs and antibiotics.

Given that the revolutionary discovery of penicillin by Alexander Fleming in 1928, antibiotics have been an essential tool in the battle against germs and infections. And although we still utilize the exact same tested approaches today, germs have progressed. When exposed to antibiotics, certain germs, fungi and parasites are able to adapt and cancel the efficiency of the drug by developing resistance.

It’s worth mentioning that antimicrobial resistance was likely to happen anyway, as the genetic code for germs modifications over time. However, it is believed that the overuse of antibiotics is an important element that speeds up the advancement of resistant pressures.

According to the World Health Organization, antimicrobial resistance “is an increasingly major hazard to international public health that requires action in all sectors of government and in society.” This has led researchers to believe outside package by attempting to determine substances that could be beneficial in the battle against damaging germs. One of these substances is cannabidiol (CBD), a cannabinoid found in Cannabis sativa.

Researchers are searching for new ways to attack infections and resistant germs.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that CBD works against Gram-positive germs. Strains of Gram-positive germs include Staphylococcus aureus (common in skin infections) and Streptococcus pneumoniae (common in bacterial pneumonia).

Dr. Blaskovich presented his findings at a yearly meeting of the American Society for Microbiology. In vitro samples of both kinds of gram-positive germs were treated with synthetic CBD. The results led Dr. Blaskovich to the conclusion that CBD operates at levels similar to those of prescription antibiotics vancomycin and daptomycin. He likewise found that CBD appeared to work against gram-positive pressures of resistant germs, which lots of standard antibiotics are starting to stop working.

” In particular, the activity was chosen against the resistant pressures of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low propensity to induce resistance and was active against MRSA biofilms. “

The team likewise carried out another research study using topical CBD to treat a skin infection in mice. Again, although the results were positive, CBD did not appear to remove the infection, however simply to decrease the number of bacterial cells.

Could CBD end up being an antibiotic?

While it is simple to hail this work as a significant breakthrough in the anti-bacterial abilities of CBD, it is prematurely to give up on penicillin.

Although it is believed that the efficiency of CBD could originate from the way it attacks the biofilm surrounding bacterial cells, the authors are still not sure of the system of action of CBD. They likewise did not think twice to point out the drawbacks of the research study. Dr. Blaskovich explained that considering that the results are in the initial stages, it is far too early for individuals to begin treating their CBD infections themselves.

The research study was likewise carried out in vitro (outside the body), and there is a risk that the results of medical trials will not be the same. A number of substances have shown anti-bacterial effectiveness in petri dishes, however then failed at this vital stage. It should likewise be mentioned that the two studies were carried out in collaboration with CBD Anything, a pharmaceutical business specializing in topical CBD products, such as those from CBD Rise.

However, this research could be an important step forward for CBD and the battle against antimicrobial resistance. CBD continues to have a great safety profile and is not considered poisonous even in large amounts. Thankfully, Dr. Blaskovich and his team plan to continue their research.

Scroll to top